封面
市場調查報告書
商品編碼
1632600

全球合成橡膠輸液幫浦市場:市場規模、佔有率和趨勢分析(按產品、應用、最終用途、地區和細分市場,2025-2030 年)

Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

合成橡膠輸液幫浦的市場趨勢:

2024 年全球合成橡膠輸液幫浦市場價值預估為 6.798 億美元,預估 2025 年至 2030 年期間複合年成長率為 7.2%。

癌症、糖尿病和心血管疾病等慢性病發生率的上升是市場成長的主要動力。根據世界衛生組織(WHO)統計,慢性病是全球首要死亡原因,佔全球整體的71%。這導致對合成橡膠幫浦等持續藥物傳輸系統的需求增加,以確保有效治療和管理這些疾病。

對居家醫療解決方案的需求不斷成長是推動合成橡膠輸液幫浦產業發展的關鍵因素。患者更喜歡可以在家中用藥的治療治療方法,合成橡膠幫浦的便攜性和易用性滿足了這項需求。人口老化進一步加強了這一趨勢,對慢性病的長期治療的需求更大。根據2024年10月發表的一項研究,骨髓炎在美國每年影響約5萬人,兒童、老年人和男性的發生率較高。椎骨和長骨是最常受影響的部位。此外,本研究和其他已發表的有關該疾病的資料也證明,男性骨髓炎的發生率高於女性。

製造商正專注於增強合成橡膠輸液幫浦技術以推動市場成長。這些進步包括更高的精度、更長的注射時間、更完善的泵浦的開發以及更易於設計。這些創新旨在滿足患者和醫療保健提供者的多樣化需求,並使合成橡膠輸液幫浦更加高效、可靠和安全。 2024 年 9 月發表在《生物科學與醫學雜誌》上的一項研究提出了一種可透過導管輸送藥物的合成橡膠泵的理論模型。在這項研究中,準確地再現了臨床流速,並確定了與球體半徑相關的毒性凸起。研究人員得出結論,透過最佳化幫浦的特性,可以控制輸液時間,同時最大限度地減少毒性作用。

減少鴉片類藥物成癮和改善患者獲得替代疼痛管理解決方案的機會的日益成長的動力是醫療政策改變的主要驅動力。 2024年11月,Avanos Medical, Inc.報告稱,醫療保險和醫療補助服務中心已完成2025年醫療保險醫院門診病人預付費系統和門診手術中心付費系統規則,該規則將於2025年1月1日生效。此次更新引入了《NOPAIN法案》,該法案要求醫療保險為涵蓋的非鴉片類藥物和設備提供明確的費用,以改善患者在醫院門診和外科中心獲得疼痛管理解決方案的機會。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章合成橡膠輸液幫浦市場:因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 合成橡膠輸液幫浦市場:分析工具
    • 產業分析:波特五力分析
    • PESTEL 分析

第 4 章合成橡膠輸液幫浦市場:按產品進行的估計與趨勢分析

  • 全球合成橡膠輸液幫浦市場:產品特定儀表板
  • 全球合成橡膠輸液幫浦市場:依產品進行的變化分析
  • 全球合成橡膠輸液幫浦市場依產品分類(以收益為準)
  • 定速合成橡膠輸液泵
  • 變速彈性合成橡膠輸液泵

第 5 章合成橡膠輸液幫浦市場:按應用進行評估與趨勢分析

  • 全球合成橡膠輸液幫浦市場:按應用分類的儀表板
  • 全球合成橡膠輸液幫浦市場:按應用進行的變化分析
  • 全球合成橡膠輸液幫浦市場按應用分類(以收益為準)
  • 疼痛管理
  • 化療
  • 抗生素/抗病毒治療
  • 其他

第 6 章合成橡膠輸液幫浦市場:依最終用途的估計與趨勢分析

  • 全球合成橡膠輸液幫浦市場:依最終用途分類的儀表板
  • 全球合成橡膠輸液幫浦市場:依最終用途進行的變化分析
  • 全球合成橡膠輸液幫浦市場按最終用途分類(以收益為準)
  • 醫院
  • 門診手術中心
  • 其他

第 7 章合成橡膠輸液幫浦市場:區域估計與趨勢分析(按國家、產品、應用和最終用途)

  • 區域控制面板
  • 市場規模預測及趨勢分析(2018年及2030年)
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 最新趨勢和影響分析:按主要製造商
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 主要企業市場佔有率分析(2024年)
  • 公司簡介
    • Baxter
    • Fresenius Kabi AG
    • B. Braun SE
    • Ambu A/S
    • Leventon, SAU
    • NIPRO
    • Terumo Corporation
    • AVNS
    • Vygon Group
    • Smiths Group plc
Product Code: GVR-4-68040-340-4

Elastomeric Infusion Pumps Market Trends:

The global elastomeric infusion pumps market size was estimated at USD 679.8 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030. The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a significant driver for market growth. According to statistics from the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for 71% of all deaths globally. This led to a higher demand for continuous drug delivery systems such as elastomeric pumps to ensure effective treatment and management of these conditions.

The growing demand for home healthcare solutions is a crucial factor driving the elastomeric infusion pumps industry. Patients prefer therapies that enable them to administer medications at home, and the portability and user-friendliness of elastomeric pumps cater to this need. This trend is amplified by the aging population's increasing requirement for long-term treatment of chronic conditions. According to a study published in October 2024, Osteomyelitis affects around 50,000 people annually in the U.S., with higher incidence in children, older adults, and males. Vertebrae and long bones are the most commonly involved sites. It also shows that males are more susceptible to Osteomyelitis than females, as evidenced by the current research and other published data on the disease.

Manufacturers are focusing on enhancing elastomeric infusion pump technologies to drive market growth. These advancements involve greater accuracy, longer infusion durations, developing pumps with improved features, and accessible designs. These innovations aim to cater to the diverse needs of patients and healthcare providers, enhancing the efficiency of elastomeric infusion pumps and making them dependable and secure. In September 2024, research published in the Journal of Biosciences and Medicines presented a theoretical model for elastomeric pumps, which deliver medications through a catheter. The study accurately reproduced clinical flow rates and identified a toxicity bump related to the sphere's radius. The researchers concluded that by optimizing pump properties, infusion times can be controlled while minimizing toxicity effects.

The increasing push to reduce opioid dependence and improve patient access to alternative pain management solutions has been a major driver in healthcare policy changes. In November 2024, Avanos Medical, Inc. reported that the Centers for Medicare and Medicaid Services has finalized its Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System regulations for 2025, set to take effect on January 1, 2025. This update introduces the NOPAIN Act, which requires Medicare to provide distinct payments for eligible non-opioid medications and devices to improve patient access to pain management solutions in hospital outpatient and surgical center environments.

Global Elastomeric Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global elastomeric infusion pumps market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Continuous Rate Elastomeric Infusion Pumps
  • Variable Rate Elastomeric Infusion Pumps
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Pain Management
  • Chemotherapy
  • Antibiotic/Antiviral Therapy
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Elastomeric Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Rising number of orthopedic surgeries
      • 3.2.1.3. Technological advancements in elastomeric infusion pumps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of elastomeric infusion pumps
      • 3.2.2.2. Regulatory standards
  • 3.3. Elastomeric Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Elastomeric Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. Global Elastomeric Infusion Pumps Market: Product Dashboard
  • 4.2. Global Elastomeric Infusion Pumps Market: Product Movement Analysis
  • 4.3. Global Elastomeric Infusion Pumps Market by Product, Revenue
  • 4.4. Continuous Rate Elastomeric Infusion Pumps
    • 4.4.1. Continuous Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Variable Rate Elastomeric Infusion Pumps
    • 4.5.1. Variable Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Elastomeric Infusion Pumps Market: Application Estimates & Trend Analysis

  • 5.1. Global Elastomeric Infusion Pumps Market: Application Dashboard
  • 5.2. Global Elastomeric Infusion Pumps Market: Application Movement Analysis
  • 5.3. Global Elastomeric Infusion Pumps Market by Application, Revenue
  • 5.4. Pain Management
    • 5.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Chemotherapy
    • 5.5.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Antibiotic/Antiviral Therapy
    • 5.6.1. Antibiotic/antiviral therapy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Elastomeric Infusion Pumps Market: End Use Estimates & Trend Analysis

  • 6.1. Global Elastomeric Infusion Pumps Market: End Use Dashboard
  • 6.2. Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
  • 6.3. Global Elastomeric Infusion Pumps Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Elastomeric Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Baxter
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Fresenius Kabi AG
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. B. Braun SE
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Ambu A/S
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Leventon, S.A.U.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. NIPRO
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Terumo Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. AVNS
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vygon Group
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Smiths Group plc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global elastomeric infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 30 France elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 31 France elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 52 China elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 53 China elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 58 India elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 59 India elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Elastomeric infusion pumps market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Elastomeric Infusion Pumps Market: Product Outlook Key Takeaways
  • Fig. 15 Global Elastomeric Infusion Pumps Market: Product Movement Analysis
  • Fig. 16 Global Continuous Rate Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Variable Rate Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Elastomeric Infusion Pumps Market: Application Outlook Key Takeaways
  • Fig. 19 Global Elastomeric Infusion Pumps Market: Application Movement Analysis
  • Fig. 20 Global Pain Management Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Chemotherapy Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Antibiotic/Antiviral Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Elastomeric Infusion Pumps Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
  • Fig. 26 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Elastomeric Infusion Pumps Market: Region Movement Analysis
  • Fig. 32 North America Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 33 US Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia pacific Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework